Table 5.
Frequency of MMR-deficiency in endometrioid endometrial cancer in various status
|
Possibility of LS*
(%) |
MMR-deficient
N (%) |
Clinical scenario |
|---|---|---|
| 7.65 | 8/17 (47) | FH of cancer (+) |
| 3.1 | 14/74 (19) | FH of cancer (-) |
| 11.4 | 7/10 (70) | FH of LS-associated cancer (+) |
| 3 | 15/81 (18.5) | FH of LS-associated cancer (-) |
| 3.94 | 22/91 (24.2) | Total |
*LS: Lynch Syndrome